Johnson & Johnson - Other Operating Expenses
Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Operating-Expenses" stands at -0.2 Billion United States Dollars for the trailing twelve months (TTM) period ending 12/31/2024, the highest value at least since 12/31/2013, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.40 Billion United States Dollars compared to the value the year prior.
The 1 year change is 1.40 Billion United States Dollars.
The 3 year change is 2.50 Billion United States Dollars.
The 5 year change is 12.76 Billion United States Dollars.
The 10 year change is 2.40 Billion United States Dollars.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2018, to it's latest available value, on 12/31/2024, is +29.96 Billion.
The Serie's change in United States Dollars from it's maximum value, on 12/31/2024, to it's latest available value, on 12/31/2024, is 0.0 Billion.
Other Operating Expenses for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Other Operating Expenses | 905,699,262,464.00 |
 | AbbVie Inc - Other Operating Expenses | 399,570,305,024.00 |
 | Roche Holding AG - Other Operating Expenses | 317,433,206,677.55 |
 | AstraZeneca PLC - Other Operating Expenses | 280,205,508,085.11 |
 | Novartis AG - Other Operating Expenses | 255,096,620,580.91 |